$76.81 -0.03 (%) Eli Lilly & Co - New York Stock Exchange, Inc.

Jan. 20, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Incyte Poised To Outperform Biotech Industry On Strong Pipeline

    Investors Business Daily | Jan. 20, 2017 | 11:00AM EST
  2. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily | Jan. 19, 2017 | 16:34PM EST
  3. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily | Jan. 19, 2017 | 13:06PM EST
  4. Trump Twitter Hangover Keeps Biotech Stocks Down

    TalkMarkets | Jan. 19, 2017 | 01:30AM EST
  5. Lilly Regains Key Migraine Drug With $960 Million CoLucid Acquisition

    Investors Business Daily | Jan. 18, 2017 | 11:25AM EST
  6. FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    Investors Business Daily | Jan. 17, 2017 | 14:21PM EST
  7. Trump + Stocks: The Week In Review

    TalkMarkets | Jan. 13, 2017 | 19:44PM EST
  8. Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference

    Investors Business Daily | Jan. 13, 2017 | 07:30AM EST
  9. Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva

    Investors Business Daily | Jan. 12, 2017 | 14:00PM EST
  10. Lilly Nears FDA Nod On Arthritis Drug, But Chemo Med Stuck In Court

    Investors Business Daily | Jan. 4, 2017 | 13:26PM EST
  11. Two Key FDA Decisions To Watch Out For In January 2017

    TalkMarkets | Jan. 2, 2017 | 15:29PM EST
  12. Amgen Plans Robust 2017 In Alzheimer's, Migraines, Oncology: CEO Exclusive

    Investors Business Daily | Jan. 2, 2017 | 08:15AM EST
  13. J&J Back In Talks With Actelion, Teva Settles Corruption Probe

    TalkMarkets | Dec. 23, 2016 | 13:37PM EST
  14. Gilead Is A Hail Mary: 3 Better Stocks To Consider

    TalkMarkets | Dec. 23, 2016 | 12:21PM EST
  15. Two Lessons From My Biogen Trade

    TalkMarkets | Dec. 22, 2016 | 12:52PM EST
  16. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  17. AskSlim Market Week - 12/16/16

    TalkMarkets | Dec. 16, 2016 | 20:34PM EST
  18. The FDA: Small-Cap Catalyst Or Small-Cap Killer?

    TalkMarkets | Dec. 16, 2016 | 09:37AM EST
  19. Lilly Spikes Post Alzheimer's Flop On Street-Topping 2017 Guidance

    Investors Business Daily | Dec. 15, 2016 | 11:43AM EST
  20. Global Stocks Jump, Dow Set For 16th Post-Election Record High After UniCredit Restructuring; Fed Looms

    TalkMarkets | Dec. 13, 2016 | 06:57AM EST
  21. Johnson & Johnson Boosted By Barron's Call For Rally

    TalkMarkets | Dec. 12, 2016 | 13:00PM EST
  22. Will Trump Break With Republicans And Push Major Drug Price Reform?

    Investors Business Daily | Dec. 10, 2016 | 09:42AM EST
  23. Biogen Underplays Promising Alzheimer's Data On Seizure Worries

    Investors Business Daily | Dec. 9, 2016 | 16:01PM EST
  24. Biogen Alzheimer's Drug Shows More Promise; Lilly Data Tonight

    Investors Business Daily | Dec. 8, 2016 | 20:52PM EST
  25. Week In Review: Suzhou's Innovent Biologics Announces Record $260 Million Funding

    TalkMarkets | Dec. 3, 2016 | 12:30PM EST
  26. Lilly Could Pocket $1.7 Billion In Fresh Diabetes Drug Sales In 2025

    Investors Business Daily | Dec. 2, 2016 | 16:35PM EST
  27. Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF

    TalkMarkets | Nov. 28, 2016 | 11:59AM EST
  28. Askslim Market Week - 11/25/16

    TalkMarkets | Nov. 25, 2016 | 22:00PM EST
  29. Eli Lilly Stock Suffers Setback With Alzheimer’s Drug Failure

    TalkMarkets | Nov. 24, 2016 | 13:14PM EST
  30. Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink

    TalkMarkets | Nov. 24, 2016 | 00:03AM EST
  31. Dow Jones Industrial Average Hits New Record In Afternoon Trading

    TalkMarkets | Nov. 23, 2016 | 22:16PM EST
  32. Eli Lilly Shares Tank As Alzheimer Drug Fails Clinical Trial

    TalkMarkets | Nov. 23, 2016 | 12:17PM EST
  33. Today's Trading Plan: The Bull Chaser

    TalkMarkets | Nov. 23, 2016 | 11:37AM EST
  34. Paid To Wait? Eli Lilly Crashes To 2 Year Lows, Erases 6 Years Of Dividends After Failed Drug Test

    TalkMarkets | Nov. 23, 2016 | 10:21AM EST
  35. Morgan Stanley Expects Big Reversal Today In Biogen Shares

    TalkMarkets | Nov. 23, 2016 | 10:00AM EST
  36. 5 Pharma Stocks In Focus On World Diabetes Day

    TalkMarkets | Nov. 14, 2016 | 13:21PM EST
  37. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  38. Pricing Issues Continue To Weigh On The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 20:01PM EST
  39. Eli Lilly Plunges To 7 Month Lows After Bernie Sanders Tweet

    TalkMarkets | Nov. 1, 2016 | 14:16PM EST
  40. Why After A Massive Run, CoLucid Shares Still Look Attractive

    TalkMarkets | Oct. 31, 2016 | 09:02AM EST
  41. 5 Healthcare Stocks To Buy Despite A Clinton Victory

    TalkMarkets | Oct. 25, 2016 | 14:07PM EST
  42. Merck & Co., Inc. Surges After Earnings, Eli Lilly and Co. Slips

    TalkMarkets | Oct. 25, 2016 | 09:10AM EST
  43. Largest Dow Component 3M Reports In Line Earnings, Cuts Top End Of Guidance

    TalkMarkets | Oct. 25, 2016 | 08:31AM EST
  44. Morning Call For October 25, 2016

    TalkMarkets | Oct. 25, 2016 | 08:05AM EST
  45. Biotech Lilly Upgraded On Alzheimer's Drug's $7.5 Billion Potential

    IBD | Sep. 27, 2016 | 15:25PM EST
  46. Biosimilars In Limelight On FDA Approval Of Amgen Drug

    TalkMarkets | Sep. 27, 2016 | 12:30PM EST
  47. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
  48. Southern Company Leads 52 Stocks Going Ex-Dividend Next Week

    Dividend.com | Aug. 4, 2016 | 07:00AM EST
  49. Biogen Stock Pops As Merck, Allergan Reportedly Probing Buyout

    Investors Business Daily | Aug. 2, 2016 | 14:49PM EST
  50. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 09:46AM EST
Trading Center